Study the Safety and Efficacy of Bone Marrow Derived Autologous Cells for the Treatment of Optic Nerve Disease

NCT01834079 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Optic Atrophy

Interventions

BIOLOGICAL: STEM CELL THERAPY

Sponsor

Chaitanya Hospital, Pune